SCHEMBL6785682

SCHEMBL6785682

O=C1CCC(Cc2ccc(Cl)cc2)CC1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.50
MAOB P27338 2/20 0.42
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
FPR2 P25090 4/20 0.41
PROKR1 Q8TCW9 4/20 0.41
GRIN1 Q05586 2/20 0.40
TSHR P16473 2/20 0.40
GMNN O75496 1/20 0.40
TP53 P04637 1/20 0.40
CYP3A4 P08684 1/20 0.40
ALOX15 P16050 1/20 0.40
NFKB1 P19838 1/20 0.40
THPO P40225 1/20 0.40
MTOR P42345 1/20 0.40
BLM P54132 1/20 0.40
GRIN2B Q13224 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
RPS6KB1 P23443 1/20 0.40
LMNA P02545 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27487290 0.89 ALDH1A1 (0.44) ALDH1A1MAOBMEN1KMT2AFPR2
SCHEMBL1119467 0.83 ALDH1A1 (0.59) ALDH1A1MEN1KMT2AFPR2PROKR1
SCHEMBL8634508 0.81 ALDH1A1 (0.36) ALDH1A1MEN1KMT2ALMNASLC6A2
SCHEMBL4364820 0.81 ESR2 (0.53) GRIN1GRIN2B
SCHEMBL8008639 0.81 OPRM1 (0.42) GRIN1LMNA
SCHEMBL5846563 0.81 EPHX2 (0.42) GRIN1TSHRGMNNTP53CYP3A4
SCHEMBL5675291 0.80 GBA1 (0.57) ALDH1A1GRIN2B
SCHEMBL4436738 0.79 GLA (0.52) ALDH1A1MEN1KMT2ACYP3A4LMNA
SCHEMBL3130172 0.78 ALDH1A1 (0.51) ALDH1A1MEN1KMT2AFPR2PROKR1
SCHEMBL25838949 0.78 ALDH1A1 (0.54) ALDH1A1CYP3A4LMNASLC6A2SLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6686373-B2 ANALGESICS; ANTIINFLAMMATORY AGENT WARNER-LAMBERT COMPANY LLC 2004-02-03 US disclosed
US-20030130277-A1 Pyrazoloquinolinone derivatives as protein kinase C inhibitors KAWAMURA KIYOSHI (JP) 2003-07-10 US disclosed
EP-1310498-A2 Pyrazoloquinolinone derivatives as protein kinase C inhibitors PFIZER INC. (US) 2003-05-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030130277-A1 Pyrazoloquinolinone derivatives as protein kinase C inhibitors PRKCB, PRKCA, PRKCG ALDH1A1 3069/4885MAOB 4602/4885MEN1 4326/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.